Developments in biological psychiatry: clinical applications to the major psychoses.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Hospital & community psychiatry

• Publication date

  1982-05-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1176/PS.33.5.355PMID 6122640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Delusional and nondelusional unipolar depression: further evidence for distinct subtypes.

  1981cited by this paper
• 'Second generation' antidepressant drugs.

  1981cited by this paper
• Propranolol in Schizophrenia

  1981cited by this paper
• DL‐propranolol and chlorpromazine following admission for schizophrenia

  1981cited by this paper
• Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression.

  1981cited by this paper
• Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review.

  1981cited by this paper
• A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.

  1981cited by this paper
• Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter".

  1981cited by this paper
• Computerised tomographic scan changes in manic-depressive illness.

  1981cited by this paper
• Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.

  1981cited by this paper
• Acute amphetamine response predicts antidepressant and antipsychotic responses to lithium carbonate in schizophrenic patients.

  1981cited by this paper
• Delusional depression. A distinct clinical entity?

  1981cited by this paper
• Serotonin uptake in blood platelets of psychiatric patients.

  1981cited by this paper
• A Trial of Propranolol in Chronic Schizophrenia

  1981cited by this paper
• Propranolol in Schizophrenia

  1981cited by this paper
• Possible linkage between primary affective disorder susceptibility locus and HLA haplotypes.

  1981cited by this paper
• Neuroendocrine and neurochemical measurements in depression.

  1981cited by this paper
• Physostigmine and lithium response in the schizophrenias.

  1981cited by this paper
• Are chlorpromazine dose equivalents equivalent in serum?

  1981cited by this paper
• Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia.

  1980cited by this paper
• Research diagnostic criteria subtypes of depression. Their role as predictors of differential response to psychotherapy and drug treatment.

  1980cited by this paper
• Active and Passive Avoidance Learning in Controls and Schizophrenic Patients on Racemic Propranolol and Neuroleptics

  1980cited by this paper
• Clonidine ameliorates Gilles de la Tourette syndrome.

  1980cited by this paper
• Carbamazepine in manic-depressive illness: a new treatment.

  1980cited by this paper
• Dextroamphetamine and cortisol in depression. Morning plasma cortisol levels suppressed.

  1980cited by this paper
• Lithium response in good prognosis schizophrenia.

  1980cited by this paper
• Molecular pathology of schizophrenia: more than one disease process?

  1980cited by this paper
• Memory enhancement in Korsakoff's psychosis by clonidine: Further evidence for a noradrenergic deficit

  1980cited by this paper
• Cerebral ventricular enlargement in chronic schizophrenia. An association with poor response to treatment.

  1980cited by this paper
• Unsuspected organic disease in chronic schizophrenia demonstrated by computed tomography

  1980cited by this paper
• The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels.

  1980cited by this paper
• Propranolol in Chronic Schizophrenia: A Controlled Study in Neuroleptic-Treated Patients

  1980cited by this paper
• "Schizoaffective disorder": an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia, and affective disorder.

  1980cited by this paper
• Relevance of dopamine autoreceptors for psychiatry: preclinical and clinical studies.

  1980cited by this paper
• Prediction of treatment outcome with lithium.

  1979cited by this paper
• Prediction of antidepressant response to lithium carbonate by a 1-day administration of d-amphetamine in unipolar depressed women.

  1979cited by this paper
• Clonidine for opiate withdrawal.

  1979cited by this paper
• Multiple receptors for dopamine

  1979cited by this paper
• Influence of D‐ or DL‐propranolol and chlorpromazine on habituation of phasic electrodermal responses in schizophrenia

  1979cited by this paper
• Should plasma level monitoring of tricyclic antidepressants be introduced in clinical practice?

  1978cited by this paper
• Clonidine in opiate withdrawal.

  1978cited by this paper
• Delusional versus non-delusional depression: Neurochemical differences.

  1978cited by this paper
• Tricyclic antidepressants: therapeutic properties and affinity for alpha-noradrenergic receptor binding sites in the brain.

  1978cited by this paper
• Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research.

  1978cited by this paper
• Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain.

  1977cited by this paper
• Weight reduction in schizophrenics by molindone.

  1977cited by this paper
• Propranolol as an adjunct to the treatment of schizophrenia.

  1977cited by this paper
• Antidepressants and the muscarinic acetylcholine receptor.

  1977cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs

  1976cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

  1976cited by this paper
• Depression, Delusions, and Drug Response.

  1975cited by this paper
• Manic-Depressive Illness and Paranoid Schizophrenia: A Phenomenologic, Family History, and Treatment-Response Study

  1974cited by this paper
• Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects.

  1974cited by this paper
• Manic-depressive illness and paranoid schizophrenia. A phenomenologic, family history, and treatment-response study.

  1974cited by this paper
• HL-A, immune-response genes, and disease.

  1974cited by this paper
• The stages of mania. A longitudinal analysis of the manic episode.

  1973cited by this paper
• Parasympathetic suppression of manic symptoms by physostigmine.

  1973cited by this paper
• A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives. Report of the Veterans Administration and National Institute of Mental Health collaborative study group.

  1972cited by this paper
• The Biochemistry of Affective Disorders

  1967cited by this paper

• No citing papers are available for this paper.